MRD Detection Methodology in Solid Tumors
MRD Detection Methodology Assessment of minimal residual disease (MRD) is becoming an increasingly important tool for early detection...
Download Section
Welcome to our Download section, where you’ll find all the essential resources to streamline your sample submission process and more. Browse through a range of documents, guidelines, and detailed instructions tailored to ensure accurate and efficient collaboration. Everything you need is just a click away.
Submission information / Einsendeinformation
Submission form / Einsendeformular
Example medical report / Musterbericht
Public declaration / Öffentliche Erklärung
Additional Product Information / Annex Report
Our Blog
Lates News & Articles
Challenges and Advances in Determining MRD in Solid Tumors
MRD in Solid Tumors Minimal residual disease (MRD) refers to a small number of cancer cells that can...
Liquid Biopsy Diagnostics
Liquid Biopsy Diagnostics: Our Research is Supported by the State of North Rhine-Westphalia. "Fragmentomics by LIQOMICS" In May,...
MRD in Flüssigbiopsien
Minimale Resterkrankung (MRD) in Flüssigbiopsien (Part II) In unserem letzten Artikel haben wir uns mit der Bedeutung der...
Liquid Biopsies in Solid Tumors and MRD Testing
Solid Tumors Solid tumors are abnormal masses of tissue that develop when cells grow uncontrollably and do not...
Minimale Resterkrankung (MRD) bei Krebs
Minimale Resterkrankung (MRD) bei Krebs (Teil I) Einleitung Im Bereich der Krebsbehandlung ist die frühe und genaue Diagnose...
Fragmentomics by LIQOMICS
Exciting News: Fragmentomics by LIQOMICS We are thrilled to announce that our project, Fragmentomics by LIQOMICS, has been...
Zirkulierende Tumor-DNA (ctDNA)
Die Zukunft der Krebsdiagnostik: Zirkulierende Tumor-DNA (ctDNA) (Teil II) In unserem letzten Artikel haben wir die Grundlagen der...
LymphoVista HL assay at the ASH 2024, MRD in Hodgkin Lymphoma
LymphoVista HL Assay results presented at ASH 2024 Annual Meeting LIQOMICS, a leading innovator in cancer diagnostics, is...
Krebsdiagnostik durch ctDNA
Die Zukunft der Krebsdiagnostik: Zirkulierende Tumor-DNA (ctDNA) Die jüngsten Fortschritte in der Krebsforschung haben unser Verständnis der komplexen...
Cancer Diagnostics with ctDNA
Unlocking the Future of Cancer Diagnostics with Circulating Tumor DNA (ctDNA) Advances in cancer research have brought us...
Minimal Residual Disease (MRD) in Liquid Biopsy
Minimal Residual Disease (MRD) in Liquid Biopsy (Part II) In our previous article, we explored the importance of...
Minimal Residual Disease (MRD) in Cancer
Minimal Residual Disease (MRD) in Cancer (Part I) Introduction In the field of cancer treatment, early and accurate...
Exciting Updates for the Hematology and Oncology Community
Exciting Updates for the Hematology and Oncology Community – Minimal Residual Disease in Hodgkin Lymphoma We’re thrilled that...
Understanding Minimal Residual Disease (MRD)
Understanding Minimal Residual Disease (MRD): A Guide to Some Helpful Calculations when Analyzing ctDNA Minimal residual disease (MRD)...